Alana Harris Dent

Array ( [id] => 10477477 [patent_doc_number] => 20150362494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'METHOD FOR DETECTING A COLORECTAL LESION' [patent_app_type] => utility [patent_app_number] => 14/765432 [patent_app_country] => US [patent_app_date] => 2014-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14292 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15163763 [patent_doc_number] => 10487363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Compositions and methods for detecting neoplasia [patent_app_type] => utility [patent_app_number] => 14/762426 [patent_app_country] => US [patent_app_date] => 2014-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 38 [patent_no_of_words] => 31390 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 258 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11116362 [patent_doc_number] => 20160313337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'METHOD FOR ANALYZING INFORMATION FOR DIAGNOSIS AND KIT THEREFOR' [patent_app_type] => utility [patent_app_number] => 15/108283 [patent_app_country] => US [patent_app_date] => 2013-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12697 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11040196 [patent_doc_number] => 20160237152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'TSPAN 33 IS A CANDIDATE FOR ANTIBODY TARGETED THERAPY FOR THE TREATMENT OF B CELL HODGKIN LYMPHOMAS' [patent_app_type] => utility [patent_app_number] => 14/653572 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16162 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12408570 [patent_doc_number] => 09969789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Treatment of CD47+ disease cells with SIRP alpha-Fc fusions [patent_app_type] => utility [patent_app_number] => 14/653165 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13255 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10428967 [patent_doc_number] => 20150313978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'Novel MHC-Independent Tumor-Associated Antigens' [patent_app_type] => utility [patent_app_number] => 14/648703 [patent_app_country] => US [patent_app_date] => 2013-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9252 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9450048 [patent_doc_number] => 20140121218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'METHOD FOR TREATING OCULAR CANCER' [patent_app_type] => utility [patent_app_number] => 14/097746 [patent_app_country] => US [patent_app_date] => 2013-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14868 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14097746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338426 [patent_doc_number] => 20140065208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'PROSTATE CARCINOGENESIS PREDICTOR' [patent_app_type] => utility [patent_app_number] => 14/075814 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 44069 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330190 [patent_doc_number] => 20140056972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'ANTI-DCLK1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/073169 [patent_app_country] => US [patent_app_date] => 2013-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 37903 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11384211 [patent_doc_number] => 20170010267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'SHON AS A PROGNOSTIC BIOMARKER FOR CANCER AND AS A PREDICTOR OF RESPONSE TO ENDOCRINE THERAPY' [patent_app_type] => utility [patent_app_number] => 15/103581 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 29828 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9396483 [patent_doc_number] => 20140093890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'QUANTITATIVE ASSAYS FOR RAS P21 IN BODY FLUIDS' [patent_app_type] => utility [patent_app_number] => 14/051589 [patent_app_country] => US [patent_app_date] => 2013-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14234 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14051589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435010 [patent_doc_number] => 20140112917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'DIAGNOSTIC AND THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING PTEN AND BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 14/051761 [patent_app_country] => US [patent_app_date] => 2013-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25242 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14051761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057325 [patent_doc_number] => 09096670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Antibodies of the ED-B domain of fibronectin, their construction and uses' [patent_app_type] => utility [patent_app_number] => 14/046224 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13327 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363114 [patent_doc_number] => 20140072987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'METHODS OF DETECING BLADDER CANCER' [patent_app_type] => utility [patent_app_number] => 14/025623 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5483 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9383905 [patent_doc_number] => 20140087387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'Methods for the Treatment, the Prognostic Assessment and the Staging of Non-Small Cell Lung Cancer' [patent_app_type] => utility [patent_app_number] => 14/021807 [patent_app_country] => US [patent_app_date] => 2013-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8437 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14021807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9306519 [patent_doc_number] => 20140045193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION' [patent_app_type] => utility [patent_app_number] => 13/963922 [patent_app_country] => US [patent_app_date] => 2013-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13274 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13963922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9306066 [patent_doc_number] => 20140044740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'Diagnostic and Therapeutic Targets for Leukemia' [patent_app_type] => utility [patent_app_number] => 13/953190 [patent_app_country] => US [patent_app_date] => 2013-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14702 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13953190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10318883 [patent_doc_number] => 20150203886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'Method for Cloning T Cell Receptor' [patent_app_type] => utility [patent_app_number] => 14/417049 [patent_app_country] => US [patent_app_date] => 2013-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12227 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10292247 [patent_doc_number] => 20150177246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'FUSION GENE OF CEP55 GENE AND RET GENE' [patent_app_type] => utility [patent_app_number] => 14/417052 [patent_app_country] => US [patent_app_date] => 2013-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11549 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538243 [patent_doc_number] => 20140162891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/947944 [patent_app_country] => US [patent_app_date] => 2013-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8527 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13947944 [rel_patent_id] =>[rel_patent_doc_number] =>)